Mankind Pharma Limited
MANKIND
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Sept 20263,145
Quarter ₹ crore YoY Jun 2024 2,403 +4.5% Sept 2024 2,530 +3.1% Dec 2024 2,397 +1.6% Jun 2025 2,541 +5.7% Sept 2025 2,609 +3.1% Dec 2025 2,633 +9.9% Mar 2026 2,582 — Jun 2026 2,964 +16.6% Sept 2026 3,145 +20.6% - ₹ crore
Sept 202659
Quarter ₹ crore Jun 2024 95 Sept 2024 106 Dec 2024 70 Jun 2025 64 Sept 2025 78 Dec 2025 57 Mar 2026 127 Jun 2026 34 Sept 2026 59 - ₹ crore
Sept 20263,204
Quarter ₹ crore Jun 2024 2,498 Sept 2024 2,636 Dec 2024 2,466 Jun 2025 2,606 Sept 2025 2,686 Dec 2025 2,689 Mar 2026 2,709 Jun 2026 2,998 Sept 2026 3,204 - Cost structure
- ₹ crore
Sept 2026718
Quarter ₹ crore Jun 2024 522 Sept 2024 526 Dec 2024 522 Jun 2025 585 Sept 2025 600 Dec 2025 617 Mar 2026 551 Jun 2026 684 Sept 2026 718 - ₹ crore
Sept 20262,420
Quarter ₹ crore Jun 2024 1,921 Sept 2024 1,865 Dec 2024 1,942 Jun 2025 2,112 Sept 2025 2,162 Dec 2025 2,100 Mar 2026 1,898 Jun 2026 2,241 Sept 2026 2,420 - Exceptional items and tax
- ₹ crore
Sept 2026784
Quarter ₹ crore Jun 2024 577 Sept 2024 770 Dec 2024 524 Jun 2025 494 Sept 2025 525 Dec 2025 505 Mar 2026 788 Jun 2026 757 Sept 2026 784 - ₹ crore
Sept 2026202
Quarter ₹ crore Jun 2024 93 Sept 2024 168 Dec 2024 108 Jun 2025 81 Sept 2025 66 Dec 2025 56 Mar 2026 74 Jun 2026 198 Sept 2026 202 - Profit
- ₹ crore
Sept 2026582
Quarter ₹ crore YoY Jun 2024 513 +25.5% Sept 2024 634 +34.2% Dec 2024 416 -14.5% Jun 2025 413 -19.6% Sept 2025 459 -27.7% Dec 2025 449 +7.9% Mar 2026 714 — Jun 2026 558 +35.3% Sept 2026 582 +26.8% - Per share
- ₹ per share
Sept 202614.09
Quarter ₹ per share Jun 2024 12.82 Sept 2024 15.84 Dec 2024 10.35 Jun 2025 10.00 Sept 2025 11.12 Dec 2025 10.89 Mar 2026 17.29 Jun 2026 13.53 Sept 2026 14.09 - Leverage
Debt to equity
timesSept 20260.00x
Quarter times Jun 2024 — Sept 2024 — Dec 2024 0.01x Jun 2025 0.00x Sept 2025 0.00x Dec 2025 0.00x Mar 2026 0.00x Jun 2026 0.00x Sept 2026 0.00x
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 2,403 | 2,530 | 2,397 | 2,541 | 2,609 | 2,633 | 2,582 | 2,964 | 3,145 | |
| Revenue YoY | +4.5% | +3.1% | +1.6% | +5.7% | +3.1% | +9.9% | — | +16.6% | +20.6% |
| 95 | 106 | 70 | 64 | 78 | 57 | 127 | 34 | 59 | |
| 2,498 | 2,636 | 2,466 | 2,606 | 2,686 | 2,689 | 2,709 | 2,998 | 3,204 | |
| Cost structure | |||||||||
| 522 | 526 | 522 | 585 | 600 | 617 | 551 | 684 | 718 | |
| 1,921 | 1,865 | 1,942 | 2,112 | 2,162 | 2,100 | 1,898 | 2,241 | 2,420 | |
| Exceptional items and tax | |||||||||
| 577 | 770 | 524 | 494 | 525 | 505 | 788 | 757 | 784 | |
| 93 | 168 | 108 | 81 | 66 | 56 | 74 | 198 | 202 | |
| Profit | |||||||||
| 513 | 634 | 416 | 413 | 459 | 449 | 714 | 558 | 582 | |
| Net profit YoY | +25.5% | +34.2% | -14.5% | -19.6% | -27.7% | +7.9% | — | +35.3% | +26.8% |
| Per share | |||||||||
| 12.82 | 15.84 | 10.35 | 10.00 | 11.12 | 10.89 | 17.29 | 13.53 | 14.09 | |
| Leverage | |||||||||
| Debt to equity | — | — | 0.01x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
Latest filed period ends Sept 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.